How It Works
This neurological-based solution is the first non-pharmaceutical, non-implantable medical device on the market today for those needing help with the harsh symptoms and pain during opiate and opioid withdrawal.
When individuals come to Continuum Recovery Center for the treatment of heroin, prescription pain pill dependency or other opioid addictions, our medical staff will assess their current state of health and identify areas that need attention. Once a strategic and customized addiction treatment plan has been created, opiate detox begins. We can even help patients in withdrawal from suboxone and methadone. Methadone requires the use of two devices.
If the patient would like to utilize the Bridge Device, and meets all the criteria, an approved health practitioner trained in the administration of the Bridge Device will position and connect the electro auricular device.
Carefully placed behind the patient’s ear, the Bridge Device battery-powered chip enables the nerve stimulator to go to work, calming the withdrawal symptoms and distress that typical present during the onset and throughout the opioid drug detox.
Length of Use
Depending on the type of opioid addiction, duration and frequency of use, the onset of withdrawal symptoms will range from 6 to 24 hours from the last time the drug was taken. Corresponding timelines for opioid detox and the Bridge Device will generally run for up to five days. While most of the physical symptoms will dissipate during that time, psychological symptoms may remain for a month or two.
Opioid Withdrawal Symptoms, as defined by the Clinical Opiate Withdrawal Scale, reduced and relieved the following with Bridge Device:
- Flu-like symptoms
- Stomach ache and upset
- Tearing eyes
- Runny nose
- Muscle, bone & joint pain
- Restlessness & Tremors
Backed by Data: Cases in Point in Determining Bridge Device Efficiency
There has been ample testing with the Bridge Device throughout the United States to assess its attributes in use and comprise corresponding success rates.
Case studies conducted on patients during their opioid detox provided the findings necessary to obtain FDA (Federal Drug Administration) authorization for its marketing to engage more widespread use.
Clinicians measured the Bridge Device efficacy through the utilization of the Clinical Opiate Withdrawal Scale (COWS). The higher the score, the more invasive the withdrawal symptoms were. Scores tabulated with COWS
gaged each patient’s opioid withdrawal experience, over time, by monitoring their symptoms before administering the Bridge Device and after.
In one such study of 73 patients, clinicians tracked their instances and levels of body shakes, anxiety, sweating, digestive issues, joint aches, bone pain, pupil size, and resting pulse rate.
The difference in patients’ symptomology before the Bridge Device and after was apparent.
Perhaps the most compelling information about the benefits of the Bridge Device to a patient amidst opioid drug detox is in the visible evidence of relief. Watch the video accounts of patients and their personal experience with this detox treatment system.
For more information on the Bridge Device, refer to the most common questions and their answers here.